Cargando…
A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming
Direct reprogramming of cardiac fibroblasts (CFs) to induced cardiomyocytes (iCMs) is a newly emerged promising approach for cardiac regeneration, disease modeling, and drug discovery. However, its potential has been drastically limited due to the low reprogramming efficiency and largely unknown und...
Autores principales: | Zhou, Yang, Alimohamadi, Sahar, Wang, Li, Liu, Ziqing, Wall, Joseph B., Yin, Chaoying, Liu, Jiandong, Qian, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878887/ https://www.ncbi.nlm.nih.gov/pubmed/29743891 http://dx.doi.org/10.1155/2018/3814747 |
Ejemplares similares
-
Molecular barriers to direct cardiac reprogramming
por: Vaseghi, Haley, et al.
Publicado: (2017) -
Single Cell Transcriptomics Reconstructs Fate Conversion from Fibroblast to Cardiomyocyte
por: Liu, Ziqing, et al.
Publicado: (2017) -
An Optimized Protocol for Human Direct Cardiac Reprogramming
por: Garbutt, Tiffany A., et al.
Publicado: (2020) -
Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming
por: Wang, Li, et al.
Publicado: (2020) -
Epigenetic Modifiers Are Necessary but Not Sufficient for Reprogramming Non-Myelinating Cells into Myelin Gene-Expressing Cells
por: Liu, Jia, et al.
Publicado: (2010)